Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-01-07 @ 6:39 AM
Study NCT ID:
NCT03823560
Status:
UNKNOWN
Last Update Posted:
2021-01-06
First Post:
2019-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Performance and Safety of Class IIb MD Celegyn® in VVA
Sponsor:
Nathura S.p.A
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-24
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-09
Completion Date Type:
ESTIMATED
First Submit Date:
2019-01-23
First Submit QC Date:
None
Study First Post Date:
2019-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-05
Last Update Post Date:
2021-01-06
Last Update Post Date Type:
ACTUAL